By: Josh Welsh
GLP-1s top drug plan spend reports, but the retrospective data to justify the investment doesn't exist yet, says iA's Frédéric Leblanc
Josh Welsh is a journalist in the Wealth vertical for Key Media. He covers a range of topics including finance, investment, and workforce issues, with a particular focus on retirement planning, asset management, and mental health in the workplace. Josh's work has been featured in Wealth Professional Canada Magazine, CFP Board, InvestmentNews, and several other notable publications.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Canada (National)
Not enough data
Josh Welsh's coverage spans personal finance, wealth management, and investment strategies. He heavily cites data and seeks expert commentary to provide insights on the financial advisory industry. Pitches to him should offer access to credible experts with in-depth knowledge of financial advising, retirement planning, or investment strategies.
Given his focus on data-driven content and expert perspectives, pitches can highlight original research or unique insights that would add value to his articles. Additionally, topics related to emerging trends in the financial advisory industry may resonate well with him.
Since Josh does not have a specified geographic focus and covers a wide range of business-related themes such as human resources & employment alongside personal finance and wealth management; relevant sources from any location could be pertinent for providing insightful commentary within these areas.
This information evolves through artificial intelligence and human feedback. Improve this profile .